Arcadia Biosciences Future Growth
Future criteria checks 2/6
Arcadia Biosciences is forecast to grow earnings and revenue by 42.5% and 20.3% per annum respectively while EPS is expected to grow by 47.5% per annum.
Key information
42.5%
Earnings growth rate
47.5%
EPS growth rate
| Food earnings growth | 13.2% |
| Revenue growth rate | 20.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash Wisely
Mar 01
Arcadia Biosciences to raise $5M in securities offering
Aug 15Arcadia Biosciences: Market Still Unconvinced Of Its Health Offerings
Nov 29We Think Shareholders Should Be Aware Of Some Factors Beyond Arcadia Biosciences' (NASDAQ:RKDA) Profit
Nov 22The Future Looks Bright For Arcadia Biosciences
Dec 01Arcadia Biosciences EPS misses by $0.06
Nov 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 8 | -4 | N/A | N/A | 1 |
| 12/31/2025 | 7 | -2 | N/A | N/A | 2 |
| 12/31/2024 | 5 | -4 | N/A | N/A | 1 |
| 9/30/2024 | 5 | -7 | -12 | -12 | N/A |
| 6/30/2024 | 5 | -8 | -13 | -13 | N/A |
| 3/31/2024 | 5 | -6 | -15 | -15 | N/A |
| 12/31/2023 | 5 | -13 | -15 | -15 | N/A |
| 9/30/2023 | 5 | -10 | -14 | -14 | N/A |
| 6/30/2023 | 5 | -10 | -14 | -14 | N/A |
| 3/31/2023 | 5 | -15 | -13 | -13 | N/A |
| 12/31/2022 | 7 | -11 | -14 | -14 | N/A |
| 9/30/2022 | 9 | -17 | -18 | -18 | N/A |
| 6/30/2022 | 10 | -17 | -24 | -23 | N/A |
| 3/31/2022 | 9 | -21 | -27 | -26 | N/A |
| 12/31/2021 | 7 | -15 | -27 | -26 | N/A |
| 9/30/2021 | 12 | 4 | -27 | -26 | N/A |
| 6/30/2021 | 10 | -1 | -26 | -25 | N/A |
| 3/31/2021 | 9 | -5 | -28 | -26 | N/A |
| 12/31/2020 | 8 | -5 | -33 | -30 | N/A |
| 9/30/2020 | 1 | -20 | -31 | -28 | N/A |
| 6/30/2020 | 1 | -28 | -28 | -25 | N/A |
| 3/31/2020 | 1 | -14 | -25 | -22 | N/A |
| 12/31/2019 | 1 | -29 | -19 | -17 | N/A |
| 9/30/2019 | 1 | -23 | -16 | -15 | N/A |
| 6/30/2019 | 1 | -5 | -16 | -15 | N/A |
| 3/31/2019 | 1 | -15 | -15 | -15 | N/A |
| 12/31/2018 | 1 | -13 | -14 | -14 | N/A |
| 9/30/2018 | 2 | -16 | -14 | -14 | N/A |
| 6/30/2018 | 3 | -25 | N/A | -12 | N/A |
| 3/31/2018 | 3 | -22 | N/A | -12 | N/A |
| 12/31/2017 | 4 | -16 | N/A | -14 | N/A |
| 9/30/2017 | 3 | -18 | N/A | -16 | N/A |
| 6/30/2017 | 4 | -18 | N/A | -17 | N/A |
| 3/31/2017 | 3 | -19 | N/A | -17 | N/A |
| 12/31/2016 | 3 | -20 | N/A | -17 | N/A |
| 9/30/2016 | 4 | -18 | N/A | -17 | N/A |
| 6/30/2016 | 5 | -18 | N/A | -17 | N/A |
| 3/31/2016 | 5 | -18 | N/A | -17 | N/A |
| 12/31/2015 | 5 | -21 | N/A | -15 | N/A |
| 9/30/2015 | 7 | -21 | N/A | -14 | N/A |
| 6/30/2015 | 7 | -25 | N/A | -13 | N/A |
| 3/31/2015 | 6 | -26 | N/A | -15 | N/A |
| 12/31/2014 | 7 | -22 | N/A | -15 | N/A |
| 9/30/2014 | 6 | -21 | N/A | -15 | N/A |
| 6/30/2014 | 7 | -16 | N/A | -14 | N/A |
| 3/31/2014 | 7 | -13 | N/A | -10 | N/A |
| 12/31/2013 | 6 | -13 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RKDA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RKDA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RKDA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RKDA's revenue (20.3% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: RKDA's revenue (20.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RKDA's Return on Equity is forecast to be high in 3 years time